Production (Stage)
Avanos Medical, Inc.
AVNS
$12.31
-$0.17-1.36%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 833.33% | -3,883.81% | -- | 102.64% | -80.00% |
| Total Depreciation and Amortization | -15.79% | -3.48% | -- | -1.74% | -5.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.14% | 11,838.24% | -- | -90.50% | 288.89% |
| Change in Net Operating Assets | 124.55% | 862.71% | -- | 161.94% | -13.99% |
| Cash from Operations | 421.25% | 355.91% | -20.96% | 1,169.23% | -17.65% |
| Capital Expenditure | -63.41% | 18.64% | -- | -47.50% | -2.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -100.00% | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -355.00% | -109.38% | 75.46% | 9.23% | 50.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -135.34% | 71.74% | -- | 0.00% | 46.30% |
| Issuance of Common Stock | -20.00% | -- | -- | -- | -16.67% |
| Repurchase of Common Stock | 75.82% | 98.44% | -- | -34.62% | -727.27% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -4,057.14% | 76.11% | -134.26% | -21.95% | 96.83% |
| Foreign Exchange rate Adjustments | 250.00% | -362.50% | -- | 28.57% | -233.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.08% | 196.39% | -112.65% | 217.99% | 62.81% |